Sound Choice Pharmaceutical Instit… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

Theresa Deisher

Phone

2069069922

Tax Period

2024-01-01 to 2024-12-31

Sound Choice Pharmaceutical Institute, founded in 2008, is a micro nonprofit in the Medical Research sector that reported $9K in total revenue in fiscal year 2024. Revenue decreased 13% compared to the prior year. Expenses of $8K left a modest 7% surplus.

Mission

The corporation is organized for: 1) Promotion of public education and awareness about the widespread use of exploited humans for biomedical research and drug development; 2) certification of drugs and therapeutics free from the practice; and 3) research & development & support of organizations developing alternatives

Program Service Accomplishments

Program 1

Expenses: $5,415 Revenue: $9,020

Scientific Research & Development

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $9,020

Program Service Revenue $0

Investment Income $5

Other Revenue $0

TOTAL REVENUE $9,025

Expense Breakdown

Grants Paid $4,783

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $5,415

Other Expenses $3,603

TOTAL EXPENSES $8,386

Year-over-Year Comparison

	2024	2023	Change
Revenue	$9,025	$10,427	-0.1%
Expenses	$8,386	$76,036	-0.9%
Net Income	$639	$-65,609	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Theresa Deisher	President	1.00	Officer Director	$0	$0	$0
Mia Lor	Operations Mgr	1.00	Key Emp	$0	$0	$0
Laurie LaTour	Controller	1.00	Key Emp	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$9,025	$8,386	$9,195	$639
2023	$10,427	$76,036	$104,372	$-65,609
2022	$108,178	$78,858	$171,870	$29,320
2021	$40,956	$107,015	$143,141	$-66,059
2020	$87,599	$119,947	$97,690	$-32,348
2019	$62,605	$170,622	$224,894	$-108,017

Sound Choice Pharmaceutical Institute